Literature DB >> 2577136

Mechanisms of resistance to cisplatin and alkylating agents.

T C Hamilton, G M Lai, M L Rothenberg, A T Fojo, R C Young, R F Ozols.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2577136     DOI： 10.1007/978-1-4613-1601-5_10

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


× No keyword cloud information.
  8 in total

Review 1.  Resistance to cytostatic drugs at the cellular level.

Authors:  C P Vendrik; J J Bergers; W H De Jong; P A Steerenberg
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  In vitro interactions between platinum analogues in human ovarian-carcinoma cell lines.

Authors:  R P Perez; K M Perez; L M Handel; T C Hamilton
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

3.  AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas.

Authors:  J Q Cheng; A K Godwin; A Bellacosa; T Taguchi; T F Franke; T C Hamilton; P N Tsichlis; J R Testa
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

4.  High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis.

Authors:  A K Godwin; A Meister; P J O'Dwyer; C S Huang; T C Hamilton; M E Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

5.  Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer.

Authors:  Xi Xia; Quanfu Ma; Xiao Li; Teng Ji; Pingbo Chen; Hongbin Xu; Kezhen Li; Yong Fang; Danhui Weng; Yanjie Weng; Shujie Liao; Zhiqiang Han; Ronghua Liu; Tao Zhu; Shixuan Wang; Gang Xu; Li Meng; Jianfeng Zhou; Ding Ma
Journal:  BMC Cancer       Date:  2011-09-21       Impact factor: 4.430

6.  Exosomes as mediators of platinum resistance in ovarian cancer.

Authors:  Jennifer Crow; Safinur Atay; Samagya Banskota; Brittany Artale; Sarah Schmitt; Andrew K Godwin
Journal:  Oncotarget       Date:  2017-02-14

7.  The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines.

Authors:  P Mistry; L R Kelland; G Abel; S Sidhar; K R Harrap
Journal:  Br J Cancer       Date:  1991-08       Impact factor: 7.640

8.  A Synthetic Lethality Screen Using a Focused siRNA Library to Identify Sensitizers to Dasatinib Therapy for the Treatment of Epithelial Ovarian Cancer.

Authors:  Harsh B Pathak; Yan Zhou; Geetika Sethi; Jeff Hirst; Russell J Schilder; Erica A Golemis; Andrew K Godwin
Journal:  PLoS One       Date:  2015-12-04       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.